Though the prevalence of elderly patients diagnosed with cancer is increasing with improving life expectancy, use of tumor-directed therapy in the oldest individuals remains controversial. The goal of our study was to analyze historical trends in radiation therapy (RT) for patients 85 years and older to determine how RT utilization has changed over time and how this may inform current and future use in this age group. The National Cancer Institute’s Surveillance, Epidemiology, and End Results database (SEER-18) was interrogated for patients ≥85 years of age who received RT for either local, regional, or metastatic disease. Patients were categorized by primary disease site and decade when they received treatment. Primary site included head and neck, colorectal, breast, gynecologic, prostate, lung, central nervous system (CNS), non-prostate genitourinary (GU), or other gastrointestinal (GI) cancers. Univariate analysis was used to compared characteristics of this cohort to those younger than 85. Multivariate logistic regression was done to identify factors independently associated with receiving radiation based on disease extent. A total of 1,915,296 adults (≥18 years old) were identified who received radiation therapy between 1973 and 2012. The median age was 63 and 51,759 (2.7%) were ≥85 years old. The percentage of patients receiving radiation who were ≥85 increased from 1.9% in the 1970s to 2.7% in the 2000s and 3.4% in 2011/2012. The relative percentage of ≥85 year olds receiving RT was 2.5% for locoregional disease and 3.2% for metastatic disease, with a percentage change from the 1970s to 2011/12 of +0.9% and +2.3%, respectively. By disease site, the median change in relative percentage of ≥85 year old patients receiving RT by decade over time was +1.6%. Only prostate cancer experienced a relative decline in RT usage (-0.3%). The largest relative increase in utilization between the 1970s and 2011/12 was seen in lung (+4.5%) and non-prostate GU cancers (+10.5%). Univariate analysis showed a significant difference between patients <85 and ≥85 who received RT with regard to gender, race, marital status, disease extent, and primary site (p <0.001). On multivariate analysis, age ≥85 was not independently associated with receiving radiation for distant disease (OR 1.01, 95% CI: 0.98 to 1.04, p=0.40). Patients ≥85 years old constitute an increasing percentage of patients receiving RT, particularly in recent years. Disease extent does not appear to impact relative utilization, however RT use in particular disease sites including lung and non-prostate GU demonstrated a considerable relative increase in this population. Based on these findings, further exploration of RT in the elderly can be targeted to these subpopulations.
Read full abstract